Karen Larochelle

Director, Kuvatris Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 12, 2024Shares withheld for tax 604 shares at $0.69 of Kuvatris Therapeutics, Inc.²
Jan 29, 2024Sold 78 shares at $0.48 of Kuvatris Therapeutics, Inc.³
Nov 27, 2023Sold 35 shares at $1.03 of Kuvatris Therapeutics, Inc.⁴
Oct 27, 2023Sold 1,679 shares at $0.19 of Kuvatris Therapeutics, Inc.⁵
Aug 29, 2023Sold 456 shares at $0.48 of Kuvatris Therapeutics, Inc.⁶
Aug 28, 2023Sold 2,000 shares at $0.50 of Kuvatris Therapeutics, Inc.⁶
Jul 26, 2023Shares withheld for tax 1,143 shares at $0.72 of Kuvatris Therapeutics, Inc.⁷
Apr 26, 2023Shares withheld for tax 1,143 shares at $1.61 of Kuvatris Therapeutics, Inc.⁸
Apr 26, 2023Shares withheld for tax 1,802 shares at $1.61 of Kuvatris Therapeutics, Inc.⁹
Apr 13, 2023Granted 14,000 shares of Kuvatris Therapeutics, Inc.¹⁰
Mar 9, 2023Sold 335 shares at $1.48 of Kuvatris Therapeutics, Inc.¹¹
Mar 3, 2023Sold 1,097 shares at $1.90 of Kuvatris Therapeutics, Inc.¹²
Mar 2, 2023Sold 7,736 shares at $1.94 of Kuvatris Therapeutics, Inc.¹²

The numbers on this page point here. Each one links to the record it came from.